Skip to main content
. 2022 Mar 11;76(6):586–594. doi: 10.1136/jech-2021-217293

Table 3.

Combined prevalence of type 2 diabetes and intermediate hyperglycaemia by trial arms and gender, age group and wealth tertile at the end of the study

Characteristics End-of-study diabetes and hyperglycaemia cases
Control
n (%)
mHealth
n (%)
PLA
n (%)
mHealth
aOR (95% CI)*
PLA
aOR (95% CI)*
Gender Male 799 (44.5) 720 (41.6) 455 (26.7) 0.90 (0.71 to 1.13)
p=0.347
0.42 (0.32 to 0.55)
p<0.001*
Female 1164 (57.5) 1202 (58.2) 703 (34.3) 1.02 (0.77 to 1.35)
p=0.887
0.33 (0.23 to 0.46)
p<0.001*
Age groups (years) 30–39 590 (46.7) 516 (44.8) 329 (27.3) 0.91 (0.70 to 1.19)
p=0.504
0.33 (0.23 to 0.47)
p<0.001*
40–49 509 (46.5) 512 (50.7) 310 (21.0) 1.06 (0.82 to 1.38)
p=0.631
0.43 (0.31 to 0.59)
p<0.001*
50–59 385 (54.8) 445 (55.4) 237 (32.1) 1.03 (0.79 to 1.36)
p=0.814
0.37 (0.28 to 0.51)
p<0.001*
≥60 479 (57.9) 449 (53.8) 282 (34.8) 0.87 (0.69 to 1.10)
p=0.245
0.38 (0.28 to 0.51)
p<0.001*
Wealth tertiles Most poor 623 (55.0) 661 (54.9) 507 (34.2) 0.98 (0.74 to 1.29)
p=0.870
0.40 (0.29 to 0.56)
p<0.001*
Poor 610 (48.9) 636 (48.5) 300 (25.3) 0.95 (0.74 to 1.21)
p=0.669
0.32 (0.24 to 0.44)
p<0.001*
Least poor 722 (51.7) 616 (48.6) 348 (32.3) 0.89 (0.68 to 1.16)
p=0.389
0.37 (0.27 to 0.51)
p<0.001*

*Significant at p=0.003 after Bonferroni correction.

PLA, participatory learning and action.